Literature DB >> 2169655

Lp(a): an interloper into the fibrinolytic system?

L A Miles1, E F Plow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2169655

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  27 in total

Review 1.  Myocardial infarction in patients with normal coronary arteries: proposed pathogenesis and predisposing risk factors.

Authors:  S P Pinney; L E Rabbani
Journal:  J Thromb Thrombolysis       Date:  2001-02       Impact factor: 2.300

Review 2.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

3.  Convergent evolution of apolipoprotein(a) in primates and hedgehog.

Authors:  R M Lawn; K Schwartz; L Patthy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

4.  Association of lipoprotein(a) with long-term mortality following coronary angiography or percutaneous coronary intervention.

Authors:  Zhe Feng; Hua-Long Li; Wei-Jie Bei; Xiao-Sheng Guo; Kun Wang; Shi-Xin Yi; De-Mou Luo; Xi-da Li; Shi-Qun Chen; Peng Ran; Peng-Yuan Chen; Sheikh Mohammed Shariful Islam; Ji-Yan Chen; Yong Liu; Ying-Ling Zhou
Journal:  Clin Cardiol       Date:  2017-04-26       Impact factor: 2.882

Review 5.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

6.  Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.

Authors:  N W Boonmark; X J Lou; Z J Yang; K Schwartz; J L Zhang; E M Rubin; R M Lawn
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

Review 7.  Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.

Authors:  Angelo M Scanu
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

8.  Lipoprotein (a) in type 2 diabetes mellitus: Relation to LDL:HDL ratio and glycemic control.

Authors:  Seema Singla; Kiranjeet Kaur; Gurdeep Kaur; Habir Kaur; Jasbinder Kaur; Shivani Jaswal
Journal:  Int J Diabetes Dev Ctries       Date:  2009-04

Review 9.  Lipoprotein(a) metabolism: potential sites for therapeutic targets.

Authors:  Jane Hoover-Plow; Menggui Huang
Journal:  Metabolism       Date:  2012-10-04       Impact factor: 8.694

10.  Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridaemia.

Authors:  F Pazzucconi; L Mannucci; L Mussoni; G Gianfranceschi; P Maderna; P Werba; G Franceschini; C R Sirtori; E Tremoli
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.